FT Logo (1).png
Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021
December 01, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
November 15, 2021 18:05 ET | Field Trip Health, Ltd.
Announced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead indications.Initiated a new pipeline research...
FT Logo (1).png
Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021
November 03, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET
November 02, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
October 19, 2021 07:55 ET | Field Trip Health, Ltd.
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today...
FT Logo (1).png
Field Trip Health Announces Voting Results From the Annual General and Special Meeting of Shareholders
September 24, 2021 18:10 ET | Field Trip Health, Ltd.
TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), today announced the voting results from its Annual General and Special Meeting...
FT Logo (1).png
Field Trip Health Ltd. to Participate in Four Investor Conferences in September
September 10, 2021 08:48 ET | Field Trip Health, Ltd.
TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today...
FT Logo (1).png
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
September 09, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; NASDAQ: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians
August 31, 2021 07:55 ET | Field Trip Health, Ltd.
The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip’s medical teams for...
FT Logo (1).png
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
August 16, 2021 18:12 ET | Field Trip Health, Ltd.
At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investmentsDevelopment of FT-104, a novel psychedelic molecule with...